Rationale tag sponsored by:
Rationale
-
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myo
pubmed.ncbi.nlm.nih.gov | | Article Details | Related Articles | Share